(Total Views: 635)
Posted On: 10/24/2020 9:37:31 AM
Post# of 149105
Re: jamming1092 #63047
As for being a home run or not. We know that Leronlimab works and when and how much in dose size and how often are all things the doctors can justify and prescribe as we go forward once we have a BLA. We just need to show that we work to get a EUA. If we continue to just trial for each different Covid-19 level of disease. It will be a while before we see wide spread use. Who knows... maybe we work best if we dose at Moderate and half the normal rate of SOC/placebo patients continue to Severe and then we dose again and half of those patients don’t go to critical. Then we continue to dose the critical one dose every day until nobody dies. These are possibilities for doctors to try and not left up to trials when we get a BLA. It’s far to slow to continue trials for every covid indication and to many people will die before we get through all the trials possible we can think up for dosing and length of time between.
Good doctors will figure this all out by lab results and being attentive to their occupation as doctors. If our safety continues its golden path and is what we believe it will be going forward. Then Leronlimab could work excellent for Covid. Trials won’t necessarily show all the potential we hope to see. But use in the pandemic will be written about in journals and advertised or spoken about in presentations or even word of mouth social media throughout the medical field.
We just need to get over the hump on the first trial EUA approved before we learn just what Leronlimab can actually do during this early stages of this pandemic. For this, I am excited to see the potential. We are not limited overall by only one or two early trial results. It’s just the beginning of use is all. The door will be opened for more extensive use when we get BLA approval. Then we will all figure out just how good Leronlimab is. This is what I hope will shine through for us all. A drug that works and saves lives. How it is administered or how often we dose it, should be left up to the professionals. Safety will dictate the use of Leronlimab. Let’s hope our safety record holds true. This is the most important aspect going forward as an investor or a patient. As safety allows more of a universal common sense use and ability to change doses and time between doses as doctors dial in the proper use of any drug.
Good doctors will figure this all out by lab results and being attentive to their occupation as doctors. If our safety continues its golden path and is what we believe it will be going forward. Then Leronlimab could work excellent for Covid. Trials won’t necessarily show all the potential we hope to see. But use in the pandemic will be written about in journals and advertised or spoken about in presentations or even word of mouth social media throughout the medical field.
We just need to get over the hump on the first trial EUA approved before we learn just what Leronlimab can actually do during this early stages of this pandemic. For this, I am excited to see the potential. We are not limited overall by only one or two early trial results. It’s just the beginning of use is all. The door will be opened for more extensive use when we get BLA approval. Then we will all figure out just how good Leronlimab is. This is what I hope will shine through for us all. A drug that works and saves lives. How it is administered or how often we dose it, should be left up to the professionals. Safety will dictate the use of Leronlimab. Let’s hope our safety record holds true. This is the most important aspect going forward as an investor or a patient. As safety allows more of a universal common sense use and ability to change doses and time between doses as doctors dial in the proper use of any drug.
(4)
(0)Scroll down for more posts ▼
